| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr13:96204200-96206800 |
Active TSS |
H9 Cell Line |
embryonic stem cell
|
| 2 |
chr13:96204400-96206600 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
| 3 |
chr13:96204400-96206800 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
| 4 |
chr13:96204400-96207000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 5 |
chr13:96204400-96207000 |
Active TSS |
Pancreas |
Pancrea
|
| 6 |
chr13:96204600-96206600 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
| 7 |
chr13:96204600-96206600 |
Bivalent Enhancer |
Primary B cells from cord blood |
blood
|
| 8 |
chr13:96204600-96206800 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
| 9 |
chr13:96204600-96206800 |
Bivalent/Poised TSS |
Pancreatic Islets |
Pancreatic Islet
|
| 10 |
chr13:96204600-96206800 |
Flanking Bivalent TSS/Enh |
Monocytes-CD14+_RO01746 |
blood
|
| 11 |
chr13:96204800-96206800 |
Active TSS |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
| 12 |
chr13:96205000-96206600 |
Flanking Bivalent TSS/Enh |
Primary monocytes fromperipheralblood |
blood
|
| 13 |
chr13:96205000-96206600 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
| 14 |
chr13:96205000-96206600 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
| 15 |
chr13:96205000-96206600 |
Bivalent/Poised TSS |
Brain Cingulate Gyrus |
brain
|
| 16 |
chr13:96205000-96206600 |
Bivalent/Poised TSS |
Brain Hippocampus Middle |
brain
|
| 17 |
chr13:96205000-96206800 |
Bivalent/Poised TSS |
Brain Angular Gyrus |
brain
|
| 18 |
chr13:96205000-96207000 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 19 |
chr13:96205000-96207000 |
Bivalent/Poised TSS |
Brain Inferior Temporal Lobe |
brain
|
| 20 |
chr13:96205400-96207000 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
| 21 |
chr13:96205600-96206600 |
Flanking Bivalent TSS/Enh |
Primary T cells from cord blood |
blood
|
| 22 |
chr13:96205600-96206600 |
Bivalent/Poised TSS |
GM12878-XiMat |
blood
|
| 23 |
chr13:96205600-96206800 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
| 24 |
chr13:96205600-96207200 |
Flanking Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
| 25 |
chr13:96205600-96210400 |
Weak transcription |
A549 |
lung
|
| 26 |
chr13:96205800-96206800 |
Active TSS |
Brain Dorsolateral Prefrontal Cortex |
brain
|
| 27 |
chr13:96206000-96206800 |
Bivalent/Poised TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
| 28 |
chr13:96206200-96206800 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
| 29 |
chr13:96206200-96206800 |
Active TSS |
Brain Anterior Caudate |
brain
|
| 30 |
chr13:96206200-96207000 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
| 31 |
chr13:96206200-96209800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 32 |
chr13:96206400-96206600 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
| 33 |
chr13:96206400-96206600 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 34 |
chr13:96206400-96206600 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 35 |
chr13:96206400-96206600 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 36 |
chr13:96206400-96206600 |
Flanking Bivalent TSS/Enh |
Fetal Kidney |
kidney
|
| 37 |
chr13:96206400-96206600 |
Bivalent Enhancer |
Thymus |
Thymus
|
| 38 |
chr13:96206400-96206800 |
Flanking Bivalent TSS/Enh |
ES-I3 Cell Line |
embryonic stem cell
|
| 39 |
chr13:96206400-96206800 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
| 40 |
chr13:96206400-96206800 |
Weak transcription |
Cortex derived primary cultured neurospheres |
brain
|
| 41 |
chr13:96206400-96207000 |
Bivalent Enhancer |
Rectal Mucosa Donor 31 |
rectum
|
| 42 |
chr13:96206400-96207000 |
Bivalent Enhancer |
HepG2 |
liver
|
